Longtime employee Chelsea Droste was recently announced as the new director for the entity, and her journey to her new role began many years ago.

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients ...